JM

Jim MacDonald

Chief Executive Officer

Yellowstone Biosciences

Yellowstone Biosciences Pipeline

DrugIndicationPhase
Undisclosed Platform ProgramAcute Myeloid Leukemia (AML) & other cancersPreclinical